Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIF18A is a plus-end directed microtubule motor protein crucial for cell division, particularly in chromosome congression and spindle dynamics. It is implicated as an oncogenic driver in several cancers and is being explored as a therapeutic target with small molecule inhibitors like Sovilnesib, which inhibits ATPase activity and impairs tumor cell proliferation.
Allosteric inhibition via alpha‑4 helix; microtubule depolymerization
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin family member 18A (KIF18A).